J&J completes Initial Tender Offer for Cougar

Johnson & Johnson said it completed its initial tender offer for Cougar Biotechnology and will commence subsequent offering period. According to J&J approximately 84.4 % of outstanding shares of were tendered.

Related Articles :

• Britain to Fund Prostate Cancer Pill in U-turn
• US Senate Probes Painkiller Makers, Allied Groups
• New J&J CEO Parachuting Into Tough Terrain
• Cardinal Hires New Head of Medical Business
• U.S. Medicine Spending Rose to $320 Billion Last Year

Keywords : Johnson & Johnson

• Legal
  • Terms and Conditions
  • Privacy Policy
  • Imprint
• Help
  • Contact
  • FAQ
  • Sitemap
• Participate
  • Register
  • Login
  • RSS-Feeds
• Related Publications
  • CITplus
  • IRFS&T
  • G.I.T. Laboratory Journal
  • PRO-4-PRO